Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 19 - Issue 5 - May, 2007

Feature

Case Report
Spontaneous Closure of an Iatrogenic Circumflex Coronary Artery-to-Coronary Vein Fistula
08/01/2008
Islam Bolad, MD and Lawrence O'Meallie, MD
Islam Bolad, MD and Lawrence O'Mealli...
Coronary artery fistulae are extremely rare1 and can either be congenital or acquired secondary to cardiac intervention or surgery. They have also been reported following acute myocardial infarction.2 The majority of these fistulae arise from...
Coronary artery fistulae are extremely rare1 and can either be congenital or acquired secondary to cardiac intervention or surgery. They have also been reported following acute myocardial infarction.2 The majority of these fistulae arise from...
Coronary artery fistulae are...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
9th Biennial International Andreas Gruentzig Society: New Developments in Gene
Therapy and Stem Cells for Angiogenesis in the
08/01/2008
Sigrid Nikol, MD, William W. O’Neill, MD, Joseph Babb, MD, Jorge Belardi, MD, Timothy Henry, MD, Robert Simari, MD
Sigrid Nikol, MD, William W. O’Neil...
Prof. Dr. Sigrid Nikol MD: I welcome you to this session, New Developments in Gene Therapy and Stem Cells for Angiogenesis in the Treatment of Myocardial Infarction. Initial developments of regenerative therapies were mainly angiogenesis...
Prof. Dr. Sigrid Nikol MD: I welcome you to this session, New Developments in Gene Therapy and Stem Cells for Angiogenesis in the Treatment of Myocardial Infarction. Initial developments of regenerative therapies were mainly angiogenesis...
Prof. Dr. Sigrid Nikol MD: I...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
9th Biennial IAGS Meeting: From Gene Transfer to Cell Therapy
08/01/2008
Robert Simari, MD
Robert Simari, MD
Robert Simari, MD: I appreciate this opportunity to present some general insights into the fields of gene and cell therapy, both from a perspective as an experimental biologist, as a clinician as well as from a regulatory perspective to see...
Robert Simari, MD: I appreciate this opportunity to present some general insights into the fields of gene and cell therapy, both from a perspective as an experimental biologist, as a clinician as well as from a regulatory perspective to see...
Robert Simari, MD: I appreciate...
08/01/2008
Journal of Invasive Cardiology
Case Report
Intracardiac Echocardiography Guidance for Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
08/01/2008
Fernando Alfonso, MD, PhD, Diego Martín, MD, *Felipe Fernández-Vázquez, MD
Fernando Alfonso, MD, PhD, Diego Mart...
Treatment of patients with hypertrophic obstructive cardiomyopathy (HOCM) and refractory symptoms remains a challenge.1 Surgical septal myectomy remains the classical approach for these patients.2 This therapy is associated with good initial...
Treatment of patients with hypertrophic obstructive cardiomyopathy (HOCM) and refractory symptoms remains a challenge.1 Surgical septal myectomy remains the classical approach for these patients.2 This therapy is associated with good initial...
Treatment of patients with...
08/01/2008
Journal of Invasive Cardiology
Case Report
Aspergillus Prosthetic Valve Endocarditis Causing Functional Aortic Stenosis: Initial Case Report
08/01/2008
*Brian C. Downey, MD,**Kenneth G. Warner, MD, *Carey Kimmelstiel, MD
*Brian C. Downey, MD,**Kenneth G. War...
Despite extensive advances in cardiology over the past 50 years, the definitive treatment for aortic stenosis remains unchanged. Aortic valve replacement, while employing enhanced prostheses, continues as an imperfect therapy with inherent...
Despite extensive advances in cardiology over the past 50 years, the definitive treatment for aortic stenosis remains unchanged. Aortic valve replacement, while employing enhanced prostheses, continues as an imperfect therapy with inherent...
Despite extensive advances in...
08/01/2008
Journal of Invasive Cardiology
Case Report
Acute Neuroform Stenting of a Symptomatic Petrous Dissection
08/01/2008
a,b,dRobert D. Ecker, MD, a,b,c,dElad I. Levy, MD, a,b,c,dL. Nelson Hopkins, MD
a,b,dRobert D. Ecker, MD, a,b,c,dEla...
Only two therapies for acute stroke intervention have been approved by the U.S. Food and Drug Administration: intravenous tissue plasminogen activator (tPA) and the Merci retriever (Concentric Medical, Mountainview, California). Many patients...
Only two therapies for acute stroke intervention have been approved by the U.S. Food and Drug Administration: intravenous tissue plasminogen activator (tPA) and the Merci retriever (Concentric Medical, Mountainview, California). Many patients...
Only two therapies for acute...
08/01/2008
Journal of Invasive Cardiology
Case Report
Transcatheter Closure of Coronary Artery Fistula Complicated by Myocardial Infarction
08/01/2008
Rami Kharouf, MD, Qi-Ling Cao, MD, Ziyad M. Hijazi, MD, MPH
Rami Kharouf, MD, Qi-Ling Cao, MD, Zi...
Coronary artery fistula (CAF) is a rare congenital cardiac anomaly in which a communication is present between a coronary artery and either a cardiac chamber or another vascular structure. It accounts for 0.2–0.45% of all congenital cardiac...
Coronary artery fistula (CAF) is a rare congenital cardiac anomaly in which a communication is present between a coronary artery and either a cardiac chamber or another vascular structure. It accounts for 0.2–0.45% of all congenital cardiac...
Coronary artery fistula (CAF) is...
08/01/2008
Journal of Invasive Cardiology
Case Report
Coronary Venous Angioplasty and Stenting for Biventricular Pacemaker Left Ventricular Lead Implantation
08/01/2008
*Amgad N. Makaryus, MD, Loukas Boutis, MD, Bruce Goldner, MD, Chong H. Park, MD
*Amgad N. Makaryus, MD, Loukas Boutis...
Biventricular pacing (BVP) for the treatment of congestive heart failure is now one of the forefront therapies for heart failure patients who continue to have symptoms despite maximal medical therapy. Recent advances in lead technology and...
Biventricular pacing (BVP) for the treatment of congestive heart failure is now one of the forefront therapies for heart failure patients who continue to have symptoms despite maximal medical therapy. Recent advances in lead technology and...
Biventricular pacing (BVP) for...
08/01/2008
Journal of Invasive Cardiology
Case Report
A Case of Congenitally Corrected Transposition of the Great Arteries with Rare but Life-Threatening Ventricular Tachycardia and
08/01/2008
Surender Malhotra, MBBS, Rakesh N. Patel, MBBS, *Mahendra Mandawat, MBBS
Surender Malhotra, MBBS, Rakesh N. Pa...
Congenitally corrected transposition of the great vessels (CCTGA) is a rare congenital heart defect (CHD) and constitutes less than 1% of all congenital heart disease. The two fundamental anatomic abnormalities in CCTGA consist of...
Congenitally corrected transposition of the great vessels (CCTGA) is a rare congenital heart defect (CHD) and constitutes less than 1% of all congenital heart disease. The two fundamental anatomic abnormalities in CCTGA consist of...
Congenitally corrected...
08/01/2008
Journal of Invasive Cardiology

Column

Editorial Message
May
08/01/2008
Richard E. Shaw, PhD, FACC, FACA Editor-in-Chief
Richard E. Shaw, PhD, FACC, FACA Edit...
Dear Readers,The May 2007 issue of the Journal of Invasive Cardiology includes original research articles, commentaries, a review article, clinical images, online case reports, and a continuation of discussions from the Biennial Andreas...
Dear Readers,The May 2007 issue of the Journal of Invasive Cardiology includes original research articles, commentaries, a review article, clinical images, online case reports, and a continuation of discussions from the Biennial Andreas...
Dear Readers,The May 2007 issue...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

May 2007 Volume 19 Issue 5

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement